Toronto Dominion Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35M | Sell |
78,472
-12,816
| -14% | -$5.98M | 0.05% | 295 |
|
|
2025
Q4 | $41.4M | Sell |
91,288
-13,590
| -13% | -$5.86M | 0.06% | 288 |
|
|
2025
Q3 | $41.1M | Sell |
104,878
-13,748
| -12% | -$5.75M | 0.06% | 265 |
|
|
2025
Q2 | $52.8M | Buy |
118,626
+19,472
| +20% | +$8.97M | 0.09% | 195 |
|
|
2025
Q1 | $48.1M | Sell |
99,154
-8,680
| -8% | -$4.04M | 0.09% | 173 |
|
|
2024
Q4 | $43.4M | Sell |
107,834
-26,368
| -20% | -$12.2M | 0.07% | 194 |
|
|
2024
Q3 | $62.4M | Buy |
134,202
+3,096
| +2% | +$1.49M | 0.11% | 130 |
|
|
2024
Q2 | $61.5M | Sell |
131,106
-21,853
| -14% | -$9.49M | 0.1% | 128 |
|
|
2024
Q1 | $63.9M | Buy |
152,959
+2,950
| +2% | +$1.25M | 0.1% | 135 |
|
|
2023
Q4 | $61M | Buy |
150,009
+13,796
| +10% | +$5.1M | 0.09% | 165 |
|
|
2023
Q3 | $47.4M | Sell |
136,213
-3,742
| -3% | -$1.31M | 0.08% | 197 |
|
|
2023
Q2 | $49.2M | Buy |
139,955
+10,851
| +8% | +$3.66M | 0.07% | 198 |
|
|
2023
Q1 | $40.7M | Sell |
129,104
-7,226
| -5% | -$2.17M | 0.07% | 205 |
|
|
2022
Q4 | $39.3M | Buy |
136,330
+20,190
| +17% | +$6.15M | 0.06% | 213 |
|
|
2022
Q3 | $33.6M | Sell |
116,140
-9,809
| -8% | -$2.82M | 0.06% | 213 |
|
|
2022
Q2 | $35.5M | Sell |
125,949
-5,223
| -4% | -$1.4M | 0.07% | 177 |
|
|
2022
Q1 | $34.2M | Sell |
131,172
-24,109
| -16% | -$5.72M | 0.05% | 189 |
|
|
2021
Q4 | $34.1M | Sell |
155,281
-69,234
| -31% | -$13.5M | 0.05% | 233 |
|
|
2021
Q3 | $40.7M | Buy |
224,515
+32,565
| +17% | +$6.36M | 0.06% | 177 |
|
|
2021
Q2 | $38.7M | Buy |
191,950
+48,156
| +33% | +$10.1M | 0.06% | 192 |
|
|
2021
Q1 | $30.9M | Sell |
143,794
-21,061
| -13% | -$4.63M | 0.05% | 201 |
|
|
2020
Q4 | $39M | Buy |
164,855
+13,842
| +9% | +$3.18M | 0.07% | 172 |
|
|
2020
Q3 | $41.1M | Sell |
151,013
-23,449
| -13% | -$6.47M | 0.1% | 139 |
|
|
2020
Q2 | $50.7M | Sell |
174,462
-23,925
| -12% | -$6.49M | 0.13% | 121 |
|
|
2020
Q1 | $47.2M | Sell |
198,387
-45,391
| -19% | -$10.4M | 0.14% | 118 |
|
|
2019
Q4 | $53.4M | Buy |
243,778
+45,290
| +23% | +$9.17M | 0.09% | 149 |
|
|
2019
Q3 | $33.6M | Sell |
198,488
-165,406
| -45% | -$29.3M | 0.07% | 189 |
|
|
2019
Q2 | $33.4M | Buy |
363,894
+182,029
| +100% | +$31.8M | 0.07% | 187 |
|
|
2019
Q1 | $33.4M | Buy |
181,865
+25,040
| +16% | +$4.62M | 0.05% | 200 |
|
|
2018
Q4 | $26M | Sell |
156,825
-13,390
| -8% | -$2.32M | 0.04% | 195 |
|
|
2018
Q3 | $32.8M | Buy |
170,215
+2,856
| +2% | +$509K | 0.06% | 190 |
|
|
2018
Q2 | $28.4M | Buy |
167,359
+26,300
| +19% | +$4.08M | 0.06% | 214 |
|
|
2018
Q1 | $23M | Buy |
141,059
+27,900
| +25% | +$4.56M | 0.05% | 210 |
|
|
2017
Q4 | $17M | Buy |
113,159
+13,388
| +13% | +$1.98M | 0.05% | 229 |
|
|
2017
Q3 | $15.2M | Buy |
99,771
+11,138
| +13% | +$1.68M | 0.05% | 212 |
|
|
2017
Q2 | $11.4M | Buy |
88,633
+18,737
| +27% | +$2.26M | 0.04% | 252 |
|
|
2017
Q1 | $7.64M | Buy |
69,896
+23,969
| +52% | +$2.11M | 0.02% | 302 |
|
|
2016
Q4 | $3.38M | Buy |
45,927
+35,540
| +342% | +$2.89M | 0.01% | 389 |
|
|
2016
Q3 | $907K | Buy |
10,387
+5,877
| +130% | +$555K | ﹤0.01% | 452 |
|
|
2016
Q2 | $390K | Sell |
4,510
-536
| -11% | -$46.3K | ﹤0.01% | 477 |
|
|
2016
Q1 | $400K | Sell |
5,046
-5,641
| -53% | -$510K | ﹤0.01% | 427 |
|
|
2015
Q4 | $1.35M | Sell |
10,687
-258
| -2% | -$31.1K | 0.01% | 307 |
|
|
2015
Q3 | $1.14M | Buy |
10,945
+1,065
| +11% | +$137K | 0.01% | 315 |
|
|
2015
Q2 | $1.22M | Buy |
9,880
+66
| +0.7% | +$8.32K | 0.01% | 358 |
|
|
2015
Q1 | $1.16M | Sell |
9,814
-4,681
| -32% | -$561K | 0.01% | 343 |
|
|
2014
Q4 | $1.72M | Buy |
14,495
+5,401
| +59% | +$608K | 0.01% | 314 |
|
|
2014
Q3 | $1.5M | Buy |
9,094
+38
| +0.4% | +$3.62K | 0.01% | 301 |
|
|
2014
Q2 | $857K | Buy |
9,056
+342
| +4% | +$24K | ﹤0.01% | 399 |
|
|
2014
Q1 | $629K | Buy |
8,714
+33
| +0.4% | +$2.61K | ﹤0.01% | 434 |
|
|
2013
Q4 | $644K | Buy |
8,681
+3,731
| +75% | +$260K | ﹤0.01% | 411 |
|
|
2013
Q3 | $374K | Sell |
4,950
-5,525
| -53% | -$440K | ﹤0.01% | 424 |
|
|
2013
Q2 | $839K | Buy |
+10,475
| New | +$771K | ﹤0.01% | 327 |
|
Other funds holding VRTX
VCM
VPM
Toronto Dominion Bank's VRTX Position: Q1 2026 in Review
Toronto Dominion Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 14% in Q1 2026, selling an estimated $5.98M and leaving 78,472 shares worth $35M. The position accounts for 0.05% of the portfolio, ranked #295.
Toronto Dominion Bank first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $63.9M in Q1 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Toronto Dominion Bank held 78,472 shares of Vertex Pharmaceuticals worth $35M as of Q1 2026.
- Toronto Dominion Bank sold 12,816 Vertex Pharmaceuticals shares in Q1 2026, an estimated $5.98M.
- Vertex Pharmaceuticals made up 0.05% of Toronto Dominion Bank's portfolio in Q1 2026, its #295 holding.
- Toronto Dominion Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Toronto Dominion Bank's Vertex Pharmaceuticals position peaked at $63.9M in Q1 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.